These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12868561)

  • 1. Failure of intravenous linezolid to treat Clostridium difficile associated diarrhea.
    Lazzarini L; De Lalla F
    J Chemother; 2003 Jun; 15(3):299-300. PubMed ID: 12868561
    [No Abstract]   [Full Text] [Related]  

  • 2. Metronidazole resistance in Clostridium difficile.
    Johnson S; Sanchez JL; Gerding DN
    Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole.
    Lu CL; Liu CY; Liao CH; Huang YT; Wang HP; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):311-2. PubMed ID: 20045292
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
    Baines SD; Noel AR; Huscroft GS; Todhunter SL; O'Connor R; Hobbs JK; Freeman J; Lovering AM; Wilcox MH
    J Antimicrob Chemother; 2011 Jul; 66(7):1537-46. PubMed ID: 21504940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
    Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Clostridium difficile toward antimicrobial agents used as feed additives for food animals.
    Aarestrup FM; Tvede M
    Microb Drug Resist; 2011 Mar; 17(1):125-7. PubMed ID: 20950192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.
    Moyenuddin M; Williamson JC; Ohl CA
    Curr Gastroenterol Rep; 2002 Aug; 4(4):279-86. PubMed ID: 12149168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of linezolid against Clostridium difficile.
    Peláez T; Alonso R; Pérez C; Alcalá L; Cuevas O; Bouza E
    Antimicrob Agents Chemother; 2002 May; 46(5):1617-8. PubMed ID: 11959617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
    Johnson S; Schriever C; Galang M; Kelly CP; Gerding DN
    Clin Infect Dis; 2007 Mar; 44(6):846-8. PubMed ID: 17304459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential protective role of linezolid against Clostridium difficile infection.
    Valerio M; Pedromingo M; Muñoz P; Alcalá L; Marin M; Peláez T; Giannella M; Bouza E
    Int J Antimicrob Agents; 2012 May; 39(5):414-9. PubMed ID: 22445203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
    Seiler P; Enderlin-Paput M; Pfaff P; Weiss M; Ritz D; Clozel M; Locher HH
    Antimicrob Agents Chemother; 2016 Jan; 60(1):628-31. PubMed ID: 26503650
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Freeman J; Pilling S; Vernon J; Wilcox MH
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Choice of antibiotics in diarrhea due to Clostridium difficile].
    Andersen IB; Bendtsen F
    Ugeskr Laeger; 1999 Feb; 161(8):1091-4. PubMed ID: 10074847
    [No Abstract]   [Full Text] [Related]  

  • 17. E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    Leroi MJ; Siarakas S; Gottlieb T
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):72-4. PubMed ID: 11913510
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudomembranous colitis: pathogenesis, prevention, treatment].
    Zakharova NV; Fil' TS
    Eksp Klin Gastroenterol; 2013; (12):87-91. PubMed ID: 24933996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
    Kerst JM; van der Lelie J; Kuijper EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1137-40. PubMed ID: 11433658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.